BAVA Bavarian Nordic A/S

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, March 18, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameErik Gregers Hansen
2.Reason for the notification
a)Position/status



 
Member of the Board of Directors of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
New shares





DK0061268711
b)Nature of the transactionPurchase (exercise of subscription rights)
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 1095,600
d)Aggregated information
  • Aggregated volume
  • Price
 



5,600

DKK 610,400.00
e)Date of the transaction2020-03-18
f)Place of the transactionNasdaq Copenhagen A/S, XCSE



1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameSIRIUS HOLDING ApS
2.Reason for the notification
a)Position/status



 
Closely related to Erik Gregers Hansen, member of the Board of Directors of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
New shares





DK0061268711
b)Nature of the transactionPurchase (exercise of subscription rights)
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 1094,000
d)Aggregated information
  • Aggregated volume
  • Price
 



4,000

DKK 436,000.00
e)Date of the transaction2020-03-18
f)Place of the transactionNasdaq Copenhagen A/S, XCSE



1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameMaria Tzatzaris
2.Reason for the notification
a)Position/status



 
Closely related to Paul Chaplin, President and Chief Executive Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
New shares





DK0061268711
b)Nature of the transactionPurchase (exercise of subscription rights)
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 1093,040
d)Aggregated information
  • Aggregated volume
  • Price
 



3,040

DKK 331,360.00
e)Date of the transaction2020-03-18
f)Place of the transactionNasdaq Copenhagen A/S, XCSE



1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameMaria Tzatzaris
2.Reason for the notification
a)Position/status



 
Closely related to Paul Chaplin, President and Chief Executive Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument





Identification code
Subscription rights





DK0061268638
b)Nature of the transactionSale of subscription rights
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 10.5232,000
d)Aggregated information
  • Aggregated volume
  • Price
 



32,000

DKK 336,505.60
e)Date of the transaction2020-03-10
f)Place of the transactionNasdaq Copenhagen A/S, XCSE

About Bavarian Nordic

Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacture and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and has been a long-term supplier to the U.S. Strategic National Stockpile of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against monkeypox. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an investigational Ebola vaccine, licensed to Janssen. For more information visit .

Contacts

Rolf Sass Sørensen

Vice President Investor Relations (EU)

Tel:

Graham Morrell

Paddock Circle Advisors (US)



Tel:

Company Announcement no. 12 / 2020

Attachment

EN
18/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bavarian Nordic A/S

 PRESS RELEASE

Bavarian Nordic offentliggør regnskab for første halvår 2025

Bavarian Nordic offentliggør regnskab for første halvår 2025 KØBENHAVN, Danmark, 22. august 2025 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag regnskab samt rapporterede på begivenheder for første halvår 2025. Desuden offentliggør selskabet finanskalender for 2026. Omsætningen i første halvår steg med 33% til DKK 2.998 mio., hvilket afspejler en stærk udvikling i både Travel Health og Public Preparedness. Travel Health omsætning steg med 24% til DKK 1.386 mio. sammenlignet med første halvår 2024, hvilket primært var drevet af øget efterspørgsel på vacciner mod rabies og flåtbår...

 PRESS RELEASE

Bavarian Nordic Announces First Half 2025 Results

Bavarian Nordic Announces First Half 2025 Results COPENHAGEN, Denmark, August 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2025 and released its financial calendar for 2026. Revenue for the first half increased by 33% to DKK 2,998 million, reflecting a strong performance in both Travel Health and Public Preparedness. Travel Health revenue increased by 24% to DKK 1,386 million compared to the first half of 2024, primarily driven by increased demand for rabies and tick-borne encephalitis (TBE) vaccines....

 PRESS RELEASE

Bavarian Nordic afslutter salget af Priority Review Voucher og opjuste...

Bavarian Nordic afslutter salget af Priority Review Voucher og opjusterer de økonomiske forventninger til 2025 KØBENHAVN, Danmark, 31. juli 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har afsluttet salget af sin Priority Review Voucher (PRV). Ved transaktionens afslutning har selskabet modtaget USD 160 mio. kontant. For yderligere informationer om transaktionen henvises til . Fratrukket royaltybetalingen til National Institutes of Health samt transaktionsomkostninger beløber nettoprovenuet sig til DKK 810 mio., der vil blive indregnet som andre driftsindtægter og ...

 PRESS RELEASE

Bavarian Nordic Announces Closing of Sale of Priority Review Voucher a...

Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance COPENHAGEN, Denmark, July 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the company received a cash consideration of USD 160 million. See for additional information about the PRV sale. After deduction of royalties to the National Institutes of Health and transaction costs, the net proceeds amount to DKK 810 million, which will be recognized as other operating income, and will therefore ...

 PRESS RELEASE

Konsortium ledet af Nordic Capital og Permira vil fremsætte kontant fr...

Konsortium ledet af Nordic Capital og Permira vil fremsætte kontant frivilligt anbefalet købstilbud vedrørende Bavarian Nordic MÅ IKKE UDGIVES, OFFENTLIGGØRES ELLER DISTRIBUERES, DIREKTE ELLER INDIREKTE, I ELLER TIL NOGEN JURISDIKTION, HVOR DETTE VILLE UDGØRE EN OVERTRÆDELSE AF DE RELEVANTE LOVE ELLER FORORDNINGER I DEN PÅGÆLDENDE JURISDIKTION KØBENHAVN, Danmark, 28. juli 2025 – Bavarian Nordic A/S (OMX: BAVA) (“Bavarian Nordic”) har i dag offentliggjort, at selskabet har indgået en offentliggørelsesaftale med Innosera ApS ("Tilbudsgiver"), et nystiftet selskab kontrolleret af Nordic Capit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch